Abstract 4362685: Utilizing Telemedicine to Promote Equitable Care for Higher Risk Orthotopic Heart Transplant Recipients: A Single Center Analysis

H Harveen Sekhon (UCLA Medical Center, Los Angeles, California, United States) E elizabeth vandenbogaart (UCLA Medical Center, Los Angeles, California, United States) O Otilio Castillo (UCLA Medical Center, Los Angeles, California, United States) S Sabina Aleksandrovskaya (UCLA Medical Center, Los Angeles, California, United States) S Stefanie Brennan (UCLA Medical Center, Los Angeles, California, United States) E Erin Core (UCLA Medical Center, Los Angeles, California, United States) J Julie Walden (UCLA Medical Center, Los Angeles, California, United States) S Sacha Fernandez (UCLA Medical Center, Los Angeles, California, United States) N Nancy Livingston (UCLA Medical Center, Los Angeles, California, United States) A Alexandra Monin (UCLA Medical Center, Los Angeles, California, United States) A Anca Rahman (UCLA Medical Center, Los Angeles, California, United States) Y Yoana Rivas Hernandez (UCLA Medical Center, Los Angeles, California, United States) M Mario Deng (UCLA Medical Center, Los Angeles, California, United States) M Megan Kamath (UCLA Medical Center, Los Angeles, California, United States)

Abstract

Introduction: Orthotopic heart transplantation (OHT) is the definitive treatment in patients with advanced heart failure. The medical and psychosocial complexity of OHT requires multidisciplinary care. Several tools, including the Stanford Integrated Psychosocial Assessment for Transplant (SIPAT), have been developed to objectively guide a psychosocial evaluation prior to OHT. We previously found that patients in the high-risk SIPAT categories were more likely to live in a county with greater income inequality and had significantly reduced long-term survival. Research Question: We examined whether there was a difference in healthcare utilization in a cohort of OHT recipients with high-risk versus low-risk SIPAT scores two years post-OHT. Methods: Examiners obtained patient data from a single center, retrospective cohort of 144 OHT recipients between June 2019 and January 2024. For blinding, a separate group of examiners performed SIPAT scoring. Recipients with “Excellent” or “Good” score (E/G) were compared with patients who had higher-risk scores, including “Minimum Acceptable Criteria,” “High Risk,” or “Poor” (MAC/HR/P). Chi-square and t-tests were used to study associations between SIPAT score and outcomes. Results: We found a significant difference in the average lifespan of OHT recipients between E/G and MAC/HR/P (45.7 vs 51.7 months, p=0.04). MAC/HR/P patients had an average of 50 telemedicine encounters compared to 45 (p=0.11) in the E/G group in the first year post-OHT. In the second year, there was an average of 27 telemedicine encounters versus 22 (p=0.05), respectively. There was no difference in the number of clinic visits between the MAC/HR/P group and E/G group in the first (21 vs. 19, p=0.11) or second years (6.5 vs 5.8, p=0.39) post-OHT. There was also no difference in the number of hospitalizations between the MAC/HR/P and E/G groups in the first (0.70 vs 0.64, p=0.82) or second years (0.87 vs 0.69, p=0.6) post-OHT. Conclusion: In comparison to our prior findings, this cohort showed an increase in lifespan in OHT recipients in the high-risk group. Notably, there was more telemedicine utilization in the high-risk group after the first year post-OHT. Our findings suggest that telemedicine interventions by an interdisciplinary team may contribute to decreased mortality in higher risk OHT recipients. Moreover, this could represent a low-cost, scalable, and equitable approach to improving outcomes in OHT patients with psychosocial risk factors.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

H

Harveen Sekhon

UCLA Medical Center, Los Angeles, California, United States

E

elizabeth vandenbogaart

UCLA Medical Center, Los Angeles, California, United States

O

Otilio Castillo

UCLA Medical Center, Los Angeles, California, United States

S

Sabina Aleksandrovskaya

UCLA Medical Center, Los Angeles, California, United States

S

Stefanie Brennan

UCLA Medical Center, Los Angeles, California, United States

E

Erin Core

UCLA Medical Center, Los Angeles, California, United States

J

Julie Walden

UCLA Medical Center, Los Angeles, California, United States

S

Sacha Fernandez

UCLA Medical Center, Los Angeles, California, United States

N

Nancy Livingston

UCLA Medical Center, Los Angeles, California, United States

A

Alexandra Monin

UCLA Medical Center, Los Angeles, California, United States

A

Anca Rahman

UCLA Medical Center, Los Angeles, California, United States

Y

Yoana Rivas Hernandez

UCLA Medical Center, Los Angeles, California, United States

M

Mario Deng

UCLA Medical Center, Los Angeles, California, United States

M

Megan Kamath

UCLA Medical Center, Los Angeles, California, United States